Three cycles of etoposide and cisplatin chemotherapy in clinical stage IS nonseminomatous testicular cancer
Author:
Publisher
Springer Science and Business Media LLC
Subject
Urology,Nephrology
Link
http://link.springer.com/content/pdf/10.1007/s11255-006-0038-x.pdf
Reference14 articles.
1. Einhorn EH (1997). Testicular cancer: an oncological success story. Clin Cancer Res 3(12): 2630–2632
2. Bosl GJ and Motzer RJ (1997). Testicular germ-cell cancer. N Engl J Med 337(4): 242–253
3. Stoter G and Kaye SB (1997). Importance of bleomycin in combination chemotherapy for good-prognosis testicular nonseminoma: a randomized study of the European Organization for Research and Treatment of Cancer Genitourinary Tract Cancer Cooperative Group. J Clin Oncol 15(5): 1837–1843
4. Horwich A, Sleijfer DT and Fossa SD (1997). Randomized trial of bleomycin, etoposide, and cisplatin compared with bleomycin, etoposide, and carboplatin in good-prognosis metastatic nonseminomatous germ cell cancer: a Multi-institutional Medical Research Council/European Organization for Research and Treatment of Cancer Trial. J Clin Oncol 15(5): 1844–1852
5. Saxman SB, Finch D, Gonin R and Einhorn LH (1998). Long-term follow-up of a phase III study of three versus four cycles of bleomycin, etoposide, and cisplatin in favorable-prognosis germ-cell tumors: the Indian University experience. J Clin Oncol 16(2): 702–706
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Organ Sparing Approach in Bilateral Testis Tumors: A Short Review of the Literature with a Featuring Case;Turkish Journal of Oncology;2021
2. Systemic therapy for primary and extragonadal germ cell tumors: prognosis and nuances of treatment;Translational Andrology and Urology;2020-01
3. Current management and management controversies in early- and intermediate-stage of nonseminoma germ cell tumors;Translational Andrology and Urology;2020-01
4. Testicular Cancer, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology;Journal of the National Comprehensive Cancer Network;2019-12
5. Indications for Surgery in Disseminated Seminoma;Urologic Clinics of North America;2019-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3